68
Views
17
CrossRef citations to date
0
Altmetric
Original Research

A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study

, , &
Pages 135-143 | Published online: 17 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Il Young Cho. (2019) Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases. Therapeutics and Clinical Risk Management 15, pages 1183-1206.
Read now
Masahisa Arahata & Hidesaku Asakura. (2018) Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities. Clinical Interventions in Aging 13, pages 1675-1690.
Read now

Articles from other publishers (15)

Adenike R Adelakun, Ricky D Turgeon, Mary A De Vera, Kimberlyn McGrail & Peter S Loewen. (2023) Oral anticoagulant switching in patients with atrial fibrillation: a scoping review. BMJ Open 13:4, pages e071907.
Crossref
Waleska Jaclyn Freitas Nunes de Sousa, Nathália Sernizon Guimarães, Catiane Costa Viana, Pamela Thayna Silva Machado, Amanda Fonseca Medeiros, Mayara Sousa Vianna, Renan Pedra de Souza, Caryne Margotto Bertollo & Maria Auxiliadora Parreiras Martins. (2022) Factors associated with nonadherence to the use of coumarin derivatives or direct oral anticoagulants: A systematic review of observational studies. British Journal of Clinical Pharmacology 88:11, pages 4688-4707.
Crossref
Yeyenta Mina Osasu, Richard Cooper & Caroline Mitchell. (2021) Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis. BMC Family Practice 22:1.
Crossref
Patita Sitticharoenchai, Kullaya Takkavatakarn, Smonporn Boonyaratavej, Kearkiat Praditpornsilpa, Somchai Eiam‐Ong & Paweena Susantitaphong. (2021) Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis. Journal of the American Heart Association 10:7.
Crossref
Jason Gordon, Max Norman, Michael Hurst, Thomas Mason, Carissa Dickerson, Belinda Sandler, Kevin G. Pollock, Usman Farooqui, Lara Groves, Carmen Tsang, David Clifton, Ameet Bakhai & Nathan R. Hill. (2021) Using machine learning to predict anticoagulation control in atrial fibrillation: A UK Clinical Practice Research Datalink study. Informatics in Medicine Unlocked 25, pages 100688.
Crossref
Mireille E. Schnitzer, Robert W. Platt & Madeleine Durand. (2020) A tutorial on dealing with time‐varying eligibility for treatment: Comparing the risk of major bleeding with direct‐acting oral anticoagulant s vs warfarin . Statistics in Medicine 39:29, pages 4538-4550.
Crossref
Maja Hellfritzsch, Shirley V Wang, Erik Lerkevang Grove, Joshua J Gagne, Jesper Hallas & Anton Pottegård. (2020) Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation. American Journal of Epidemiology 189:12, pages 1467-1477.
Crossref
Shota Hamada, Taro Kojima, Nobuo Sakata, Hiroshi Maruoka, Yukari Hattori, Jiro Okochi & Masahiro Akishita. (2020) Changes in use of high‐priced new drugs and drug costs among residents of long‐term care facilities under a bundled payment system: Case studies of dipeptidyl peptidase‐4 inhibitors and direct oral anticoagulants. Geriatrics & Gerontology International 20:9, pages 842-844.
Crossref
IlYoung Cho. (2019) A Review of the Medical Challenges of Using Direct Oral Anticoagulants in Real-World Practice. Therapeutic Innovation & Regulatory Science 54:4, pages 793-802.
Crossref
Susin Park & Nam Kyung Je. (2019) Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation. Journal of Cardiovascular Pharmacology and Therapeutics 25:1, pages 57-64.
Crossref
Nathan W. Hutchinson-Jones, Sophie K. Didcott, Matthew D. Jones & Josephine N. Crowe. (2020) Implementation of a standardised annual anticoagulation specialist review in primary care. Primary Health Care Research & Development 21.
Crossref
Jonathan Gospos & Nijole Bernaitis. (2019) Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia. Journal of Clinical Medicine 8:6, pages 863.
Crossref
Sara R. Vazquez. (2018) Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Hematology 2018:1, pages 339-347.
Crossref
Sara R. Vazquez. (2018) Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Blood 132:21, pages 2230-2239.
Crossref
Claudio Tana, Fulvio Lauretani, Andrea Ticinesi, Beatrice Prati, Antonio Nouvenne & Tiziana Meschi. (2018) Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson’s Disease and Parkinsonism. International Journal of Molecular Sciences 19:5, pages 1299.
Crossref